Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Methenamine Hippurate Tablets Market Today And What Is Its Future Size?

The market size for methenamine hippurate tablets has seen substantial growth in the recent past. It is anticipated to increase from $9.52 billion in 2024 to $10.11 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. This growth during the historical period can be traced back to factors such as conventional UTI treatment, worries over antibiotic resistance, clinical confirmation, physicians’ prescribing habits, and a patient preference for non-antibiotic solutions.

The market for methenamine hippurate tablets is anticipated to witness a robust expansion in the upcoming years, reaching a value of “$13.47 billion by 2029 with a compound annual growth rate (CAGR) of 7.4%. The predicted growth during this period is a result of factors such as increased occurrences of UTI, heightened worries over antibiotic resistance, progress in UTI management, an emphasis on preventive therapies in healthcare, and ongoing clinical trials and research. The period is also likely to be marked by several key trends, including a rise in UTI cases, growing antibiotic resistance, a preference for non-antibiotic solutions, a focus on preventive healthcare, along with research and development efforts.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Methenamine Hippurate Tablets Market?

The growth of the methenamine hippurate tablets market is set to be propelled by the rising geriatric population. The term “geriatric population” pertains to individuals aged 60 and above. These older patients are inherently more prone to urinary tract infections due to several factors, including diminished urine flow, a larger prostate size, or the presence of kidney stones, necessitating the use of methenamine hippurate tablets for treatment. For example, projections from the World Health Organization, a Switzerland-based United Nations agency tasked with managing global public health, suggest that one in six people globally will be 60 or older by 2030. In 2022, the global population comprised 1.4 billion people aged over 60. It is expected that by 2050, the number of individuals aged 60 or older worldwide will surge to 2.1 billion—a twofold increase. Additionally, the population of those 80 or older is estimated to triple, hitting 426 million. Consequently, the uptrend in the geriatric population is a significant driving force for the methenamine hippurate tablets market.

Which Segments Define The Structure Of The Methenamine Hippurate Tablets Market?

The methenamine hippurate tablets market covered in this report is segmented –

1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs

4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Subsegments:

1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options

2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging

What Strategic Shifts And Innovations Are Influencing The Methenamine Hippurate Tablets Market?

The emergence of product innovations is a notable trend in the methenamine hippurate tablets market, with leading companies creating fresh products to bolster their market standing. For instance, in May 2023, EQL Pharma, a European pharmaceutical company dedicated to the development and sale of economically efficient generic medicines and niche generics to hospitals and pharmacies, declared the out-licensing of Memprex (methenamine hippurate) to Laboratoires Majorelle for distribution in France. This action increased its accessibility and provided an alternative to antibiotics for UTI prevention. Laboratoires Majorelle, a well-known company in women’s health in France, will take on the marketing and distribution of Memprex, promoting it as a non-antibiotic UTI prevention option.

Who Are The Primary Market Leaders In The Methenamine Hippurate Tablets Market?

Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

What Regional Factors Are Accelerating Growth In The Methenamine Hippurate Tablets Market?

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9412&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model